COMPOUNDS USED FOR TREATING CANCER AND THE USE THEREOF
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 3, 2013
app pub date -
Dec 15, 2010
filing date -
Dec 15, 2010
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention discloses compounds for the treatment of cancer and its application. These compounds comprises one of the following compound: Ammonium pyrrolidinedithiocarbamate Bay 11-7085
BIO
Brefeldin A
(+)-Butaclamol
Calcimycin
Calmidazoliur chloride
Chelerythrine chloride
CK2 Inhibitor 2
CGP-74514A hydrochloride
CGS-12066A meleate
Dequalinium dichloride
Dihydroouabain
Diphenyleneiodonium chloride
Emetine dihydrochloride hydrate
GR 127935 hydrochloride
Nifedipine
6-Nitroso-1,2-benzopyrone
Palmitoyl-DL-Carnitine chloride
Parthenolide
PD 169316
1,10-Phenanthroline monohydrate
4-Phenyl-3-furoxancarbonitrile
Prazosin hydrochloride
Protoporphyrin IX disodium
Quinacrine dihydrochloride
Quabain
Retinoic acid p-hydroxyanilide
Rottlerin
Sanguinarine chloride
Tetraethylthium disulfide and SU 9516. The invention also provides new uses of these compounds, compounds such as for the preparation of the treatment of cancer, inhibit cancer cell, cancer stem cell growth and provides a new pharmaceutical composition for treating cancers
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully